产品
编 号:F512025
分子式:C20H19N3O3
分子量:349.38
产品类型
结构图
CAS No: 902128-92-1
联系客服
产品详情
生物活性:
E7016 (GPI 21016) is an orally available PARP inhibitor. E7016 can enhance tumor cell radiosensitivity in vitro and in vivo through the inhibition of DNA repair. E7016 acts as a potential anticancer agent.
体内研究:
E7016 has antitumor efficacy in murine xenograft studies.Administration of E7016 (40 mg/kg; oral gavage) to mice bearing U251 xenografts enhances the effectiveness of the Temozolomide/radiation combination. Mice treated with E7016/irradiation/Temozolomide have an additional growth delay of six days compared with the combination of Temozolomide and irradiation in vivo.Animal Model:Four- to six-week-old female nude mice
Dosage:40 mg/kg
Administration:Oral gavage
Result:E7016 enhanced the radiation/Temozolomide (3 mg/kg orally)-induced tumor growth delay of U251 xenografts.
体外研究:
E7016 can enhance tumor cell radiosensitivity through the inhibition of DNA repair.E7016 (3 μM)-mediated radiosensitization occurs through an increase in the number of cells undergoing mitotic catastrophe and not an increase in the number of cells undergoing apoptosis.E7016 inhibits PARP by mimicking NAD+.